文献速递乳房整形与再造

BRA评分工具在澳大利亚乳房再造患者中的预测与实际并发症对比

Predicted versus actual complications in Australian women undergoing post-mastectomy breast reconstruction: a retrospective cohort study using the BRA Score tool.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2021-06-09

本研究为澳大利亚公立医院单中心回顾性队列研究,评估BRA评分工具对乳房再造并发症的预测效能。结果显示,BRA评分对总体手术并发症、手术部位感染(SSI)和30天血清肿的预测为合理或良好,12个月假体再造的同类并发症预测也较准确,延迟与即刻再造结果相似。SSI预测最佳,在自体和假体再造中均表现良好。

要点

  • BRA评分对总体并发症、SSI和30天血清肿预测良好(C-statistic >0.7,Brier评分 <0.09)。
  • 12个月假体再造的同类并发症预测同样准确,延迟与即刻再造结果相似。
  • SSI是最佳预测并发症,在自体和假体再造中均预测良好。

核心结论

  • BRA评分风险计算器在澳大利亚公立医院中,对即刻和延迟乳房再造的部分风险预测有效。
  • SSI是预测最佳的并发症,在自体和假体再造类型中均预测良好。

研究设计与样本

  • 回顾性队列研究,数据来自澳大利亚单一公立教学医院单元的Flinders乳房再造数据库。
  • 纳入接受乳房再造的女性,包括即刻和延迟再造,比较BRA评分预测与实际并发症。
  • 采用受试者工作特征曲线下面积分析和Brier评分比较预测与观察到的并发症。

主要发现

  • BRA评分对总体手术并发症、SSI和30天血清肿的预测为合理或良好(C-statistic >0.7,Brier评分 <0.09)。
  • 对12个月假体再造的相同并发症预测同样准确。
  • 延迟与即刻再造之间的发现相似。
  • SSI是预测最佳的并发症,在自体和假体再造类型中均预测良好。

关键数值与推荐

  • 预测合理或良好定义为C-statistic >0.7且Brier评分 <0.09。
  • 评估的并发症包括总体手术并发症、SSI和血清肿(30天),以及假体再造12个月的相同并发症。

临床怎么用

  • BRA评分可用于澳大利亚公立医院中即刻和延迟乳房再造患者的风险分层。
  • SSI预测效能最佳,可优先用于自体和假体再造的感染风险沟通。

局限性

  • 回顾性单中心研究,数据来自单一澳大利亚公立教学医院单元。
  • BRA评分原始开发人群为北美仅接受即刻再造的患者,本研究外推至澳大利亚及延迟再造人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The Breast Reconstruction Risk Assessment (BRA) Score tool is a risk calculator developed to predict the risk of complications in individual patients undergoing breast reconstruction. It was developed in a North American population exclusively undergoing immediate breast reconstruction. This study sought to assess the predictions of the BRA Score tool against the measured outcomes of surgery for an Australian public hospital population, including both immediate and delayed reconstructions. METHOD: This was a retrospective cohort study of data from women at a single Australian public teaching hospital unit. Data from the Flinders Breast Reconstruction Database was retrieved and compared to BRA Scores calculated for each patient. Receiver operating curve area under the curve analysis was performed as well as Brier scores to compare predicted versus observed complications. RESULTS: BRA Score predictions were reasonable or good (C-statistic >0.7, Brier score <0.09) for the complications of overall surgical complications, surgical site infection (SSI) and seroma at 30 days, and similarly accurate for prediction of the same complications for implant reconstructions at 12 months. There were similar findings between delayed and immediate reconstructions. CONCLUSION: The BRA Score risk calculator is valid to detect some risks in both patients undergoing immediate and delayed breast reconstruction in an Australian public hospital setting. SSI is the best predicted complication and is well-predicted across both autologous and prosthetic reconstruction types.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Deek RP, Lee IOK, van Essen P, et al. Predicted versus actual complications in Australian women undergoing post-mastectomy breast reconstruction: a retrospective cohort study using the BRA Score tool. J Plast Reconstr Aesthet Surg. 2021. PMID: 34253489. doi:10.1016/j.bjps.2021.05.039

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。